Drug Shortage Report for CEFTRIAXONE SODIUM FOR INJECTION

Last updated on 2021-02-12 History
Report ID 131093
Drug Identification Number 02287633
Brand name CEFTRIAXONE SODIUM FOR INJECTION
Common or Proper name CEFTRIAXONE SODIUM INJ 1GM
Company Name TEVA CANADA LIMITED
Market Status MARKETED
Active Ingredient(s) CEFTRIAXONE
Strength(s) 1G
Dosage form(s) POWDER FOR SOLUTION
Route of administration INTRAMUSCULAR INTRAVENOUS INTRAMUSCULAR INTRAVENOUS
Packaging size 10pk
ATC code J01DD
ATC description OTHER BETA-LACTAM ANTIBACTERIALS
Reason for shortage Other (Please describe in comments)
Anticipated start date
Actual start date 2021-01-06
Estimated end date
Actual end date 2021-02-05
Shortage status Resolved
Updated date 2021-02-12
Company comments This item is discontinued
Health Canada comments
Tier 3 Status No
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v4 2021-02-12 French Compare
v3 2021-02-12 English Compare
v2 2021-01-07 French Compare
v1 2021-01-07 English Compare

Showing 1 to 4 of 4